Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Association of Mycoplasma pneumoniae in Asthma Pathogenesis

  • Marie, Mohammed Ali M. (Clinical Laboratory Department, Riyadh College of Health Sciences, King Saud University)
  • Published : 2008.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The role of atypical bacterial infection in the pathogenesis of asthma is a subject of continuing debate. There is an increasing body of literature concerning the association between the atypical bacteria such as Mycoplasma pneumoniae (M. pneumoniae) and asthma pathogenesis. Moreover, many studies investigating such a link have been uncontrolled and have provided conflicting evidence, in part due to the difficulty in accurately diagnosing infection with these atypical pathogens. This manuscript will review the relationship between M. pneumoniae infection and asthma pathogenesis.

Keywords

References

  1. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154:654-60. https://doi.org/10.1164/ajrccm.154.3.8810601
  2. Lemanske RF Jr. Is asthma an infectious disease? Chest 2003;123:385S-90S. https://doi.org/10.1378/chest.123.3_suppl.385S
  3. Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003;24:79-83.
  4. Bleecker ER, Postma DS, Meyers DA. Evidence for multiple genetic susceptibility loci for asthma. Am J Respir Crit Care Med 1997;156:S113-S6. https://doi.org/10.1164/ajrccm.156.4.12tac7
  5. Kroegel C, Jager L, Walker C. Is there a place for intrinsic asthma as a distinct immunopathological entity? Eur Respir J 1997;10:513-5.
  6. von HL. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J 2002;19:546-56. https://doi.org/10.1183/09031936.02.00254402
  7. Holgate ST, Lackie PM, Davies DE, Roche WR, Walls AF. The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy 1999;29:90-5. https://doi.org/10.1046/j.1365-2222.1999.00016.x
  8. Barnes PJ. Chapter 248. Asthma. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Co, Inc.; 2008. p. 1596-607.
  9. Vervloet LA, Marguet C, Camargos PA. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz J Infect Dis 2007;11:507-14. https://doi.org/10.1590/S1413-86702007000500012
  10. Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community- acquired pneumonia: a review of 101 hospitalized adult patients. Respiration 1996;63:261-6. https://doi.org/10.1159/000196557
  11. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003;9:263-73. https://doi.org/10.1046/j.1469-0691.2003.00590.x
  12. van Kuppeveld FJ, van der Logt JT, Angulo AF, van Zoest MJ, Quint WG, Niesters HG, et al. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol 1992;58:2606-15.
  13. Kleemola SR, Karjalainen JE, Räty RK. Rapid diagnosis of Mycoplasma pneumoniae infection: clinical evaluation of a commercial probe test. J Infect Dis 1990;162:70-5. https://doi.org/10.1093/infdis/162.1.70
  14. Uldum SA, Jensen JS, Sondergard-Andersen J, Lind K. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol 1992;30:1198-204.
  15. Sillis M. Modern methods for the diagnosis of Mycoplasma pneumoniae pneumonia. Rev Med Microbiol 1993;4:24-31. https://doi.org/10.1097/00013542-199301000-00004
  16. Luneberg E, Jensen JS, Frosch M. Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol 1993;31:1088-94.
  17. Guleria R, Nisar N, Chawla TC, Biswas NR. Mycoplasma pneumoniae and central nervous system complications: a review. J Lab Clin Med 2005;146:55-63. https://doi.org/10.1016/j.lab.2005.04.006
  18. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728. https://doi.org/10.1128/CMR.17.4.697-728.2004
  19. Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999;13:131-9. https://doi.org/10.1016/S1386-6532(99)00030-X
  20. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004;38:1341-6. https://doi.org/10.1086/392498
  21. Esposito S, Droghetti R, Bosis S, Claut L, Marchisio P, Principi N. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol 2002;34:122-7. https://doi.org/10.1002/ppul.10139
  22. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Makela MJ, Dakhama A, et al. Critical roles for interleukin- 4 and interleukin-5 during respiratory syncytial virus infection in the development of airway hyperresponsiveness after airway sensitization. Am J Respir Crit Care Med 2000;162:380-6. https://doi.org/10.1164/ajrccm.162.2.9903057
  23. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:595-601. https://doi.org/10.1067/mai.2001.113563
  24. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993;70:23-5.
  25. Thumerelle C, Deschildre A, Bouquillon C, Santos C, Sardet A, Scalbert M, et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France). Pediatr Pulmonol 2003;35:75-82. https://doi.org/10.1002/ppul.10191
  26. Seggev JS, Lis I, Siman-Tov, Gutman R, Abu-Samara H, Schey G, et al. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 1986;57:263-5.
  27. Meloni F, Paschetto E, Mangiarotti P, Crepaldi M, Morosini M, Bulgheroni A, et al. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother 2004;16:70-6.
  28. Lieberman D, Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003;167:406-10. https://doi.org/10.1164/rccm.200209-996OC
  29. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998;158:998-1001. https://doi.org/10.1164/ajrccm.158.3.9711092
  30. Tuuminen T, Edelstein I, Punin A, Kislova N, Stratchounski L. Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma. Clin Microbiol Infect 2004;10:345-8. https://doi.org/10.1111/j.1198-743X.2004.00822.x
  31. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005;172:1078-89. https://doi.org/10.1164/rccm.200412-1743PP
  32. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001;24:577-82. https://doi.org/10.1165/ajrcmb.24.5.4315
  33. Hoek KL, Cassell GH, Duffy LB, Atkinson TP. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 2002;109:470-6. https://doi.org/10.1067/mai.2002.121951
  34. Koh YY, Park Y, Lee HJ, Kim CK. Levels of interleukin- 2, interferon-gamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 2001;107:E39. https://doi.org/10.1542/peds.107.3.e39
  35. Yang J, Hooper WC, Phillips DJ, Talkington DF. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun 2002;70:3649-55. https://doi.org/10.1128/IAI.70.7.3649-3655.2002
  36. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003;71:1520-6. https://doi.org/10.1128/IAI.71.3.1520-1526.2003
  37. Opitz O, Pietsch K, Ehlers S, Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology 1996;196:575-87.
  38. Waites KB, Crabb DM, Bing X, Duffy LB. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother 2003;47:161-5. https://doi.org/10.1128/AAC.47.1.161-165.2003
  39. Clyde WA Jr. Mycoplasma pneumonaie infections of man. In: Tully JG, Whitcomb RF, editors. The mycoplasmas II. Human and animal mycoplasmas, vol. II. New York: Academic Press; 1979. p. 275-306.
  40. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin- dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother 2001;45:2604-8. https://doi.org/10.1128/AAC.45.9.2604-2608.2001
  41. Schonwald S, Kuzman I, Oreskovic K, Burek V, Skerk V, Car V, et al. Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome: a randomized study. Infection 1999;27:198-202. https://doi.org/10.1007/BF02561528
  42. Waites KB, Crabb DM, Duffy LB. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas. Antimicrob Agents Chemother 2003;47:39-42. https://doi.org/10.1128/AAC.47.1.39-42.2003
  43. Pullman J, Champlin J, Vrooman PS Jr. Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community- acquired pneumonia in adults. Int J Clin Pract 2003;57:377-84.